Moderna Inc (NASDAQ: MRNA) is back in the news. This time it regards a vaccine procurement deal. Recently, Argentina makes an official announcement of the COVID-19 vaccine supply deal with Moderna Inc.
Argentina is preparing for a third wave of the coronavirus
Sources aware of the developments went on record and stated that the agreement is an attempt by the country to strengthen its vaccination drive. The country aims to speed up the vaccination of its population. The government takes this effort to face and overcome a third wave of the pandemic if and when it hits its population.
Details of the deal not revealed by the government of Argentina
As far as the deal is concerned, both the government of Argentina and the company involved in the deal, Moderna Inc, have not revealed particulars of the agreement. U.S.-based Moderna Inc will sign the deal soon, cabinet chief Santiago Cafiero told Argentina’s Congress that. However, no mention was made by the government of Argentina or the company Moderna Inc about the deal’s particulars. Thus, it remains unclear how many doses of the vaccine will be procured, when they will be delivered, and the cost the country is making the purchase.
Chief Executive Officer of Moderna Inc comments on the deal
“We appreciate the support from the government of Argentina with this supply agreement for doses of the Moderna COVID-19 vaccine or our variant booster candidates,” said Stéphane Bancel, Chief Executive Officer of Moderna Inc. “We are committed to making our vaccine available around the world as we seek to address the pandemic with our COVID-19 vaccine.”
Argentina has vaccinated 23.7 million of its 45 million inhabitants with at least one dose of a COVID-19 vaccine. Another 4.9 million people have received two jabs. As a result, the country has recorded 4.6 million cases of COVID-19 and 97,000 related deaths. The good news is that Argentina is witnessing a drop in covid cases as of this writing.
